Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

405 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
Lim K, Kan WL, Nair PC, Kutyna M, Lopez AF, Hercus T, Ross DM, Lane S, Fong CY, Brown A, Yong A, Yeung D, Hughes T, Hiwase D, Thomas D. Lim K, et al. Among authors: yong a. PLoS One. 2024 Sep 19;19(9):e0310641. doi: 10.1371/journal.pone.0310641. eCollection 2024. PLoS One. 2024. PMID: 39298477 Free PMC article. Clinical Trial.
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.
Shanmuganathan N, Wadham C, Shahrin N, Feng J, Thomson D, Wang P, Saunders V, Kok CH, King RM, Kenyon RR, Lin M, Pagani IS, Ross DM, Yong ASM, Grigg AP, Mills AK, Schwarer AP, Braley J, Altamura H, Yeung DT, Scott HS, Schreiber AW, Hughes TP, Branford S. Shanmuganathan N, et al. Haematologica. 2023 Sep 1;108(9):2380-2395. doi: 10.3324/haematol.2022.282184. Haematologica. 2023. PMID: 36951160 Free PMC article.
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study.
Yeung DT, Shanmuganathan N, Reynolds J, Branford S, Walia M, Yong ASM, Shortt J, Chee L, Viiala N, Cunningham I, Ross DM, D'Souza A, Wright M, Harrup R, Forsyth C, Filshie R, Lane S, Browett P, Grove C, Grigg AP, Hughes TP. Yeung DT, et al. Among authors: yong asm. Blood. 2024 Nov 7;144(19):1993-2001. doi: 10.1182/blood.2024024657. Blood. 2024. PMID: 39102630
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.
Thomson AJ, Rehn JA, Heatley SL, Eadie LN, Page EC, Schutz C, McClure BJ, Sutton R, Dalla-Pozza L, Moore AS, Greenwood M, Kotecha RS, Fong CY, Yong ASM, Yeung DT, Breen J, White DL. Thomson AJ, et al. Among authors: yong asm. Cancers (Basel). 2023 Sep 26;15(19):4731. doi: 10.3390/cancers15194731. Cancers (Basel). 2023. PMID: 37835427 Free PMC article.
Microwave-Energy-Based Device for the Treatment of Cellulite and Localized Adiposity: Recommendations of the "Onda Coolwaves" International Advisory Board.
Hoffmann K, Zappia E, Bonan P, Coli F, Bennardo L, Clementoni MT, Pedrelli V, Piccolo D, Poleva I, Salsi B, Cuciti C, Tarico MS, Incandela C, Nunziata CA, D'Andrea F, Perosino E, Carpagnano S, Abramo P, Yong AA, Paschoal RS, Romero MDV, Rosas AIR, Galimberti DR, Matekovits A, Kjeldsen SH, Jensen T, Mezzana P, Msallam H, Ribero S, Nisticò SP. Hoffmann K, et al. Among authors: yong aa. Bioengineering (Basel). 2024 Dec 9;11(12):1249. doi: 10.3390/bioengineering11121249. Bioengineering (Basel). 2024. PMID: 39768067 Free PMC article. Review.
The Evolution of Treatment-Free Remission.
Hughes TP, Yong AS, Ross DM. Hughes TP, et al. Among authors: yong as. Blood. 2025 Jan 6:blood.2024026310. doi: 10.1182/blood.2024026310. Online ahead of print. Blood. 2025. PMID: 39761414
405 results